Dr. Gary Gibbons, Director of the NIH National Heart, Lung, and Blood Institute, discusses sickle cell disease (SCD), efforts that prompted SCD progress in the U.S. and globally, and the latest advances in therapeutics, potential
More: Alliance Discussion with Gary Gibbons, MD: Hope in The Fight Against Sickle Cell DiseaseJohn Crowley, Chairman and CEO of Amicus Therapeutics, discussed his personal journey with rare disease research, developing novel treatments, centering patient advocacy, and overcoming innovation barriers.
More: Alliance Discussion with John Crowley: An Innovative, Patient-Centered Approach to Rare DiseasesThe COVID-19 pandemic has been a jarring challenge to public health and economies worldwide.
More: How genetics is helping fight COVID-19The January 2020 issue of Research!America's newsletter, The Research Advocate, is now online!
More: The Research Advocate: January 2020
